Domenico Ribatti
University of Bari
965 Papers
6.1K Citations
Domenico Ribatti is an academic researcher from University of Bari. The author has contributed to research in topics: Angiogenesis & Biology. The author has an hindex of 96, co-authored 913 publications. Previous affiliations of Domenico Ribatti include University of Genoa & National Institutes of Health.
Chat about Author
Papers
In situ hybridization and immunogold localization of vascular endothelial growth factor receptor-2 on the pericytes of the chick chorioallantoic membrane.
Domenico Ribatti,Amauri Cruz,Beatrice Nico,Judith Favier,Angelo Vacca,Patrizia Corsi,Luisa Roncali,Franco Dammacco +7 more
TL;DR: VEGF may be released to promote both angiogenesis, by initiating an angiogenic response by endothelial cells expressing VEGFR-2, and the recruitment of pericytes along the capillary wall, playing also a crucial role in maturation and stabilization of the CAM blood vessels.
11
Mast cell populations in the chick embryo lung and their response to compound 48/80 and dexamethasone
TL;DR: Two mast cell populations, connective tissue mast cells (CTMCs) and mucosal mast cells, (MMCs), containing different proteoglycans in their granules, can be distinguished in several animal species by means of histochemical methods.
11
Mast cells in human digestive tube in normal and pathological conditions
TL;DR: The use of MCs' tryptase inhibitors or c-KitR tyrosine kinase inhibitors could represent a potential anti-MC therapeutic approach in all the inflammatory and tumor pathological conditions of the digestive tube in which MCs are involved.
11
Lymphocyte-Induced Angiogenesis: A Morphometric Study in the Chick Embryo Chorioallantoic Membrane
TL;DR: A morphometric analysis was carried out on the chorioallantoic membrane (CAM) vasculature in chicken embryos treated with phytohemagglutinin (PHA), with supernatants of cell cultures of normal human T lymphocytes and of T lymphocyte stimulated with PHA in order to evaluate their angiogenic properties.
11
Anti-angiogenic effects of biotechnological therapies in rheumatic diseases.
TL;DR: This review article is based on a literature research about the role of biotechnological therapies in angiogenesis inhibition and concludes that several evidences have demonstrated a role for biotehnological therapies on pathological angiogenic inhibition.